Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Large Panels Complicate Results Reporting for Breast Cancer Risk
...
Already a member? Log in here
TB Diagnosis May Be Improved With New Three-Gene Panel
...
Already a member? Log in here
Astronauts to Test Viability of Sequencing in Space
From - Diagnostic Testing & Emerging Technologies
Astronauts will soon conduct DNA sequencing in space. National Aeronautics and Space Administration's (NASA's) Biomolecule Sequencer investigation will…
Legalization of Marijuana Raises Need for Testing to Detect Impaired Drivers
From - Diagnostic Testing & Emerging Technologies
With the movement to legalize marijuana use for medical and/or recreational purposes gaining traction, states are calling for…
Luminex Acquires Nanosphere with Eye Towards Growth in Molecular Microbiology
From - Diagnostic Testing & Emerging Technologies
Luminex (Austin, Texas) announced this week it will acquire molecular microbiology firm Nanosphere (Northbrook, Ill.) in a cash deal valued at…
Orgs Plan for Personalized Medicine Growth over Next Few Years
From - Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
Global Lab Network Expands Measles, Rubella Surveillance Capacity
From - Diagnostic Testing & Emerging Technologies
From 2010 to 2015 the Global Measles and Rubella Laboratory Network (GMRLN) substantially increased its capacity to provide real-time disease surveillance and…
